TALK Talkspace, Inc.
Healthcare$5.19+0.00%OpenMarket Cap: $869.4M
As of 2026-05-26
Valuation
P/E (TTM)
110.63
PEG
0.26
P/B
7.75
P/S
3.65
EV/EBITDA
135.49
DCF Value
$-9.70
FCF Yield
-0.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
42.2%
Operating Margin
-1.2%
Net Margin
0.5%
ROE
1.0%
ROA
0.9%
ROIC
-1.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $61.7M | 41.5% | $-7.1M | $-6.3M | $— | — |
| Q4 null | $63.0M | 42.7% | $3.8M | $4.8M | $— | — |
| FY null | $228.9M | 43.0% | $3.2M | $7.8M | $— | — |
| Q3 null | $59.4M | 41.7% | $2.2M | $3.3M | $— | — |
| Q2 null | $54.3M | 43.1% | $-1.8M | $-541.0K | $— | — |
| Q1 null | $52.2M | 44.6% | $-1.1M | $318.0K | $— | — |
| Q4 null | $48.7M | 44.2% | $569.0K | $1.2M | $— | — |
| FY null | $187.6M | 45.8% | $-4.5M | $1.1M | $— | — |
| Q3 null | $47.4M | 45.6% | $99.0K | $-1.7M | $— | — |
| Q2 null | $46.1M | 45.7% | $-3.5M | $-474.0K | $— | — |
| Q1 null | $45.4M | 47.8% | $-1.7M | $-1.5M | $— | — |
| Q4 2023 | $42.4M | 49.4% | $-2.6M | $-1.3M | $-0.01 | — |